Glenn J F
Department of Surgery, University of Kentucky Medical Center, Lexington.
Urology. 1995 Jan;45(1):139-41. doi: 10.1016/s0090-4295(95)97548-9.
Hypercalcemia may be a manifestation of a variety of disorders including hyperparathyroidism, hypervitaminosis D, sarcoidosis, multiple myeloma, hyperthyroidism, acute osteoporosis, metastatic bone disease, and a number of primary malignancies. Hypercalcemia may be seen in as many as 1.5% of all patients with malignant disease, with or without bony metastases. The neoplasms most commonly associated with hypercalcemia include carcinoma of the lung (all cell types), breast cancer, squamous cell carcinomas, hematologic malignancies, and renal cell carcinoma. Observation of a number of instances of hypercalcemia attendant on urologic malignancies prompts the brief report of 4 characteristic cases with documentation of response to therapy. Management of severe and debilitating hypercalcemia is emphasized. Urologists should be aware of new agents available for such treatment.
高钙血症可能是多种疾病的表现,包括甲状旁腺功能亢进、维生素D过多症、结节病、多发性骨髓瘤、甲状腺功能亢进、急性骨质疏松症、转移性骨病以及一些原发性恶性肿瘤。在所有恶性疾病患者中,无论有无骨转移,高钙血症的发生率可达1.5%。与高钙血症最常相关的肿瘤包括肺癌(所有细胞类型)、乳腺癌、鳞状细胞癌、血液系统恶性肿瘤和肾细胞癌。对一些泌尿外科恶性肿瘤伴发高钙血症病例的观察促使我们简要报告4例典型病例,并记录治疗反应。重点强调了严重和使人衰弱的高钙血症的管理。泌尿外科医生应了解可用于此类治疗的新药物。